Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
This Month's Highlights
You have accessRestricted Access

This Month's Highlights

JASN December 2011, 22 (12) A9; DOI: https://doi.org/10.1681/ASN.2011101026
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

BASIC RESEARCH

Podocytes Require Prorenin Receptor

Podocytes express the prorenin receptor (PRR), but whether this receptor contributes to podocyte function is unknown. In this issue, Riediger et al. and Oshima et al. each generated podocyte-specific PRR-knockout mice, which develop nephrotic syndrome, and found that the PRR contributes to the proper function of protein-turnover machinery and controls lysosomal pH, which ultimately maintains cytoskeletal structure. These mice also exhibit effacement of podocyte foot processes with deranged localization of the slit diaphragm proteins nephrin and podocin. Taken together, these results demonstrate that the PRR is critical for normal podocyte structure and function. See Riediger et al., pages 2193–2202, and Oshima et al., pages 2203–2212.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

AT1A Receptors Modulate AQP2 to Concentrate Urine

The renin-angiotensin system modulates the ability to concentrate urine, but the underlying mechanisms are not completely understood. Stegbauer et al. generated mice lacking AT1A receptors in the collecting duct and found that this does not affect basal levels of plasma and urine osmolality. The lack of AT1A receptors does, however, attenuate the increase in urine osmolality in response to water deprivation or vasopressin. Furthermore, this appears to be a result of AT1A receptors directly modulating aquaporin-2 levels and not a result of differences in sodium delivery. These data provide a mechanism by which the renin-angiotensin system contributes to urinary concentration. See Stegbauer et al., pages 2237–2246.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Mouse Models Allow Study of Fibrocystin Biology

The lack of specific antibodies has limited the exploration of the biology of fibrocystin, the product of the PKHD1 gene, which leads to autosomal recessive PKD when mutated. Bakeberg et al. successfully generated a null Pkhd1 strain of mice as well as a strain that expresses an epitope-tagged endogenous fibrocystin. They report that Pkhd1 does not seem to generate many splice forms in vivo as previously thought, and that exosome-like vesicles secrete the majority of fibrocystin in its mature, cleaved form. These mouse models should promote better understanding of both the intracellular processing and shedding of fibrocystin as well as the pathophysiology of PKD. See Bakeberg et al., pages 2266–2277.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

CLINICAL EPIDEMIOLOGY

Inflammation May Explain Racial Differences in ESRD Survival

African Americans on dialysis survive longer than Caucasians, on average, but the reasons for this difference are not well understood. To determine whether inflammation may contribute, Crews et al. studied a prospective national cohort of >800 incident dialysis patients. They suggest that although African Americans have a 30% lower risk of death than Caucasians overall, this relative risk significantly varies by tertile of C-reactive protein or IL-6. Racial disparities in survival are most pronounced among patients exhibiting the most inflammation. Thus, differences in the prevalence and response to inflammation may contribute to the observed racial differences in survival on dialysis. See Crews et al., pages 2279–2286.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

CLINICAL RESEARCH

Enteral Feeding Improves Growth of Infants with CKD

Inadequate nutrition contributes to short stature among very young children with advanced CKD. Analyzing data from the International Pediatric Peritoneal Dialysis Network, Rees et al. identified significant regional variation with respect to changes in body mass index (BMI) in this population. Compared with demand feeding, they report that feeding via nasogastric tube or gastrostomy associates with greater increases in BMI. Furthermore, gastrostomy feeding, the use of biocompatible dialysate, and the use of growth hormone associate with greater linear growth. These data highlight interventions to study in clinical trials with an aim to improve growth in young children with CKD. See Rees et al., pages 2303–2312.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Bedtime Dosing of BP Medications Reduces Cardiovascular Risk

The time of day that one takes antihypertensive therapy may impact clinical outcomes, possibly by modulating sleep-time BP. Hermida et al. randomly assigned 661 patients with CKD either to take all prescribed antihypertensives in the morning or at least one of them at bedtime and followed them for a median of 5.4 yr. Those who took at least one medication at bedtime had an approximately 70% lower risk of cardiovascular events than those who took all medications in the morning. These results suggest that it may be possible to significantly reduce the risk of cardiovascular disease in CKD simply by adjusting the time of day that patients take their antihypertensive medications. See Hermida et al., pages 2313–2321.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
  • Copyright © 2011 by the American Society of Nephrology
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 22 (12)
Journal of the American Society of Nephrology
Vol. 22, Issue 12
1 Dec 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
This Month's Highlights
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
This Month's Highlights
JASN Dec 2011, 22 (12) A9; DOI: 10.1681/ASN.2011101026

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
This Month's Highlights
JASN Dec 2011, 22 (12) A9; DOI: 10.1681/ASN.2011101026
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • BASIC RESEARCH
    • CLINICAL EPIDEMIOLOGY
    • CLINICAL RESEARCH
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • This Month's Highlights
  • This Month's Highlights
  • This Month's Highlights
Show more This Month's Highlights

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals
  • Wolters Kluwer Partnership

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire